Amendment ASA1-AB862

AB862-ASA1,7,16 (d) The moneys received by the corporation related to a settlement of legal or equitable claims regarding opioids with any person or entity that engages in or has engaged in the manufacture, marketing, promotion, distribution, or dispensing of an opioid product, including any persons or entities named as defendants in the proceeding titled In re: National Prescription Opiate Litigation, Case No.: MDL 2804, are allocated as follows after taking into consideration par. (e):

AB862-ASA1,7,19 1. Fifteen percent of the moneys received by the corporation shall be allocated to the state. The corporation shall release these moneys to the department of health services upon application to the corporation by the department of health services.

AB862-ASA1,7,21 2. Fifteen percent of the moneys received by the corporation shall be allocated to the counties as determined by agreement of the counties.

AB862-ASA1,7,23 3. After taking into account subds. 1. and 2., the remaining proceeds shall be used in the manner determined by the board.

AB862-ASA1,8,2 (e) If attorney fees and costs have not been paid before the receipt of settlement proceeds under this subsection by the corporation, the board may consider an application for attorney fees and costs and may pay attorney fees and costs from the proceeds received by the corporation.

AB862-ASA1,8,6 (f) The articles of incorporation or bylaws of the corporation state that the corporation shall not have members and that a purpose of the corporation is to receive, invest, manage, and administer moneys for the purpose of abating the opioid epidemic.

AB862-ASA1,8,11 (g) Each board member shall serve as a fiduciary of the corporation, separate and distinct from any representational capacity of the entity or person nominating or appointing the board member. The board shall manage and invest moneys and conduct all matters of the corporation consistent with the responsibility as a fiduciary to the corporation.

AB862-ASA1,8,14 (h) Any moneys determined by the board of the corporation to require investment may be delivered to the investment board to be invested by the investment board under s. 25.17 (1) (kq).

AB862-ASA1,8,18 (i) The corporation complies with open meetings laws under subch. V of ch. 19 as if the corporation is a governmental body, as defined in s. 19.82 (1), and complies with open records law under subch. II of ch. 19 as if the corporation is an authority, as defined in s. 19.32 (1).

AB862-ASA1,8,23 (j) The corporation authorizes no expenditure of proceeds of opioid-related settlements unless the expenditure is in accordance with any applicable court order and the expenditure is either an actual and reasonable administrative expense or is included in a comprehensive abatement plan and is consistent with any of the following purposes:

AB862-ASA1,8,25 1. Supporting clinical and evidence-based research and treatment efforts in this state to prevent and remedy opioid addiction.

AB862-ASA1,9,2 2. Supporting cost-effective opioid prevention and cessation programs, including programs that do any of the following:

AB862-ASA1,9,4 a. Improve access to medications that have been proven to prevent or reverse an opioid overdose and support recovery.

AB862-ASA1,9,5 b. Support peer support specialists.

AB862-ASA1,9,7 c. Support screening, brief intervention, and referral to treatment services in hospitals and correctional facilities.

AB862-ASA1,9,8 d. Support access to crisis beds and residential treatment services.

AB862-ASA1,9,10 e. Expand and establish mobile crisis response systems and crisis stabilization centers.

AB862-ASA1,9,11 f. Enforce laws regarding opioid prescriptions and sales.

AB862-ASA1,9,14 g. Build provider capacity for an integrated medical home model that coordinates substance abuse treatment between regional providers that provide ongoing care.

AB862-ASA1,9,16 h. Generally mitigate the growing opioid crisis through treatment, harm reduction, education, training, and law enforcement.

AB862-ASA1,9,18 i. Support access to foster care and child protective services for children and families dealing with opioid addiction.

AB862-ASA1,9,21 j. Improve access to opioid use treatment for high-risk populations, including children and adolescents, pregnant women, and infants who have been exposed in utero to opioids.

AB862-ASA1,9,23 k. Improve the public health of the citizens of this state by addressing issues arising as a result of past, present, and future use of opioid pain medications.

AB862-ASA1,9,25 (k) Annually, the corporation submits to the attorney general, the cochairpersons of the joint committee on finance, and each county clerk a report describing the activities of the corporation, reporting any expenditures of the corporation, and reporting any outcomes achieved by the expenditure.

AB862-ASA1,10,4 (3) Nothing in this section shall alter any local government's right to pursue, litigate, or resolve its claims.

AB862-ASA1,8 Section 8. Nonstatutory provisions.

AB862-ASA1,10,8 (1) Notwithstanding s. 165.12 (2) (a) 5., the initial terms of the members under that subdivision shall be staggered so as to have one member's term expire in 2022, one member's term expire in 2023, and two members' terms expire in 2024.

AB862-ASA1,10,11 (2) Notwithstanding s. 165.12 (2) (a) 6., the initial terms of the members under that subdivision shall be staggered so as to have one member's term expire in 2022, one member's term expire in 2023, and two members' terms expire in 2024.

AB862-ASA1,10,14 (3) Notwithstanding s. 165.12 (2) (a) 7., the initial terms of the members under that subdivision shall be staggered so as to have one member's term expire in 2023 and one member's term expire in 2024.

AB862-ASA1,10,15 (End)